Literature DB >> 15996246

Laparoscopic donor distal pancreatectomy for living donor pancreas and pancreas-kidney transplantation.

Miguel Tan1, Raja Kandaswamy, David E R Sutherland, Rainer W G Gruessner.   

Abstract

With the proliferation and expanding applications of laparoscopic techniques, we determined the applicability of the laparoscopic approach to living pancreas donation. We performed the first laparoscopic donor distal pancreatectomy in 1999. We herein present our initial experience with five hand-assisted laparoscopic donor pancreatectomies. Three donors underwent distal pancreatectomy alone; two underwent a simultaneous left nephrectomy. The mean donor age was 48.4+/-8.7 years with a body mass index of 23.7 kg/m2. The donor and recipient survival rate was 100% at up to 3 years of follow-up. There were no episodes of pancreatitis, leaks, or pseudocysts. All donors returned to their preoperative state of health and to work. None of the donors have required oral anti-diabetic medications or insulin. We conclude that laparoscopic donor distal pancreatectomy is a safe and efficient procedure; hand-assisted laparoscopic distal pancreatectomy appears to be preferable, because of the added margin of safety from increased tactile feedback and ease of pancreatic dissection. The procedure can be accomplished with a single 6-cm periumbilical incision and only two 12-mm ports, resulting in excellent cosmesis and high donor satisfaction.

Entities:  

Mesh:

Year:  2005        PMID: 15996246     DOI: 10.1111/j.1600-6143.2005.00950.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  9 in total

1.  Laparoscopic cholecystectomy only could be an appropriate treatment for selected clinical R0 gallbladder carcinoma.

Authors:  C M Kang; G H Choi; S H Park; K S Kim; J S Choi; W J Lee; B R Kim
Journal:  Surg Endosc       Date:  2007-05-04       Impact factor: 4.584

2.  Landscape of Living Multiorgan Donation in the United States: A Registry-Based Cohort Study.

Authors:  Macey L Henderson; Sandra R DiBrito; Alvin G Thomas; Courtenay M Holscher; Ashton A Shaffer; Mary Grace Bowring; Tanjala S Purnell; Allan B Massie; Jacqueline M Garonzik-Wang; Madeleine M Waldram; Krista L Lentine; Dorry L Segev
Journal:  Transplantation       Date:  2018-07       Impact factor: 4.939

3.  Laparoscopic spleen-preserving distal pancreatectomy in elderly subjects: splenic vessel sacrifice may be associated with a higher rate of splenic infarction.

Authors:  Keith M Baldwin; Steven C Katz; N Joseph Espat; Ponnandai Somasundar
Journal:  HPB (Oxford)       Date:  2011-09       Impact factor: 3.647

Review 4.  Minimally invasive pancreatic surgery: the new frontier?

Authors:  Basil J Ammori; Saleh Baghdadi
Journal:  Curr Gastroenterol Rep       Date:  2006-04

5.  Adhesion of pancreatic beta cells to biopolymer films.

Authors:  S Janette Williams; Qun Wang; Ronal R Macgregor; Teruna J Siahaan; Lisa Stehno-Bittel; Cory Berkland
Journal:  Biopolymers       Date:  2009-08       Impact factor: 2.505

Review 6.  State of the art of robotic surgery in organ transplantation.

Authors:  Ivo Tzvetanov; Lorena Bejarano-Pineda; Pier C Giulianotti; Hoonbae Jeon; Raquel Garcia-Roca; Francesco Bianco; José Oberholzer; Enrico Benedetti
Journal:  World J Surg       Date:  2013-12       Impact factor: 3.352

7.  Tolerance of Vascularized Islet-Kidney Transplants in Rhesus Monkeys.

Authors:  V Pathiraja; V Villani; M Tasaki; A J Matar; R Duran-Struuck; R Yamada; S G Moran; E S Clayman; J Hanekamp; A Shimizu; D H Sachs; C A Huang; K Yamada
Journal:  Am J Transplant       Date:  2016-08-09       Impact factor: 8.086

Review 8.  Laparoscopic distal pancreatectomy: up-to-date and literature review.

Authors:  Maurizio Iacobone; Marilisa Citton; Donato Nitti
Journal:  World J Gastroenterol       Date:  2012-10-14       Impact factor: 5.742

Review 9.  Laparoscopic pancreatic resection: the past, present, and future.

Authors:  Kyoichi Takaori; Nobuhiko Tanigawa
Journal:  Surg Today       Date:  2007-06-26       Impact factor: 2.540

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.